Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by snuff133on Dec 10, 2020 9:37am
240 Views
Post# 32075758

News government grants and subsidy

News government grants and subsidy

Ventripoint Diagnostics Receives Wage Subsidy

V.VPT 

(TheNewswire) 

 

Toronto, Ontario – The Newswire – December 10, 2020 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT OTC:VPTDF) announces that it is receiving an additional temporary wage subsidy of up to $115,408 as part of the National Research Council of Canada Industrial Research Assistance Program’s (NRC IRAP) Innovation Assistance Program (IRAP IAP). 

This funding follows on support of $73,093 through IRAP IAP, which was part of approximately $150,000 in government grants, loans and subsidies received at that time (see NR Sept 15, 2020). The Company has continued to receive other loans and subsidies and so the total amount of government support has been approximately $300,000 to date in 2020.


<< Previous
Bullboard Posts
Next >>